US 11459372
Gene-edited natural killer cells
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11459372 (Gene-edited natural killer cells) held by CRISPR THERAPEUTICS AG expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K40/15